Skip to main content

Should researchers deliberately infect volunteers with coronavirus to test vaccines?

Healthcare professional gives a person a vaccine.
(Image: © Shutterstock)

If there's a single clear note rising from the cacophony of coronavirus news, it's that the pandemic will not end without a vaccine. Though dozens of vaccine candidates are in the works, some hopping through clinical trial phases at an unprecedented speed, infectious disease experts are saying that it will take at least 12 to 18 months until  a coronavirus vaccine could be ready for use in the general public — and that's in the best-case scenarios.

But experts are now proposing a slightly outlandish, ethically questionable idea: a so-called "human challenge study" that would deliberately expose volunteers to the coronavirus to quickly understand whether or not candidate vaccines work and if they are safe. More than 20,000 people around the world have already expressed interest in participating in such a challenge, if it were ever to be brought to light.

"I just want this to be solved already," a person from Romania wrote on a website called 1daysooner, an online initiative that's tallying the number of people who would volunteer for a human challenge trial. An individual from Kenya also expressed willingness to participate, writing on the site: "I am a journalist who reports in and on the developing world, and participating would both allow me to perhaps contribute in a small way to helping the sorts of people I report on." 

Related: 13 coronavirus myths busted by science

Such human challenge studies are risky for the volunteers, so they aren't typically conducted — but they have been done before. In 2018, researchers at Saint Louis University in Missouri created what they dubbed "Hotel Influenza" to house volunteers and deliberately expose them to the flu in order to test the efficacy of flu vaccines, according to a previous Live Science report

That same year, in a study looking at the effects of a bacteria on the immune system rather than at the efficacy of a vaccine, researchers exposed 34 people in the United Kingdom to whooping cough bacteria, according to another Live Science report. Similar, sometimes controversial trials have gleaned important information on diseases or treatment of diseases including cholera, typhoid, dengue, malaria, and yellow fever, according to a commentary published in the journal Trials in Dec. 2019.

All of these human challenge studies were conducted on volunteers who were made aware of the risks of such an exposure, in contrast to some barbaric studies conducted in the past on people — such as prisoners, mentally disabled people and black people — without informed consent.

But even with such transparency and consent, is such a trial ethical?

'A whole world in peril'

If the answer to that question is "yes", there's a second question: Is it right to expose people to a disease when there isn't a treatment?

"We do save people from dying from COVID but it's hard, we don't have a magic drug to pull them back," said Arthur Caplan, head of the division of medical ethics at the NYU Grossman School of Medicine. Even so, given the immensity of the situation, "it's hard to argue that we shouldn't try something that should speed up the process of finding a vaccine."

After all, "this isn't taking on a single disease in a small population; this is a whole world in peril," Caplan told Live Science. "So I think the cost-benefit makes sense." 

In a study published online  April 20 in the journal Vaccine, entitled "Extraordinary diseases require extraordinary solutions," Caplan and Dr. Stanley Plotkin, the physician who invented the rubella vaccine in 1964, concluded that despite the dangers, it is ethical to recruit volunteers who would be made sure to fully understand the known and unknown risks of being exposed to the virus, which include permanent disability and death. 

Related: Why COVID-19 kills some people and spares others

On May 6, the World Health Organization also published a set of "key criteria for the ethical acceptability" of such SARS-CoV-2 human challenge studies. The criteria include having a "strong scientific justification" for conducting the study and making sure the benefits outweigh the risks.

Human challenge studies shave months —  if not years — off conventional vaccine trials, Caplan said. That's because in a typical trial, tens of thousands of people are given a vaccine and then the researchers wait for a proportion of participants to be naturally infected with the virus to see if the vaccine worked. Measuring how many antibodies the body produces in response to the vaccine isn't enough to determine if a person is immune.

Related: After recovering from COVID-19, are you immune?

So "you're depending on natural infection and that can ebb and flow," Caplan said, noting that a number of COVID-19 treatment studies  have already ended prematurely because they started when COVID-19 was rampant in an area and then struggled to recruit enough people when new infections declined.

The fastest vaccines ever created still took 4 to 5 years to make, most take 15 to 20 years, Caplan said. "Now, we have a lot of people all of a sudden all working on one disease, and I don't think that's ever happened." Such focus could mean a faster vaccine timeline, he added.

But still, the bottleneck is studying the safety and efficacy of the vaccine, which "doesn't speed up no matter how many people are working on it," he added.

Without challenge studies, a vaccine is very unlikely to make it into our hands before at least 2 years from start to finish — that's even assuming that the first vaccines tested will work effectively, he said. During that time, many more people will die of COVID-19, he added. 

These types of studies, which would involve hundreds rather than thousands of participants, could quickly assess whether or not the vaccine works, if it has adverse effects and how much immunity it imparts. Still such a challenge is  "risky... no doubt about that," Caplan said.

"The proposal's coming from one of the world's top bioethicists, we can't just dismiss it as a crazy idea," said Michael Kinch, the associate video chancellor and director for the centers for research innovation in biotechnology and drug discovery at Washington University in St. Louis, who was not part of the study. "It is obviously unprecedented, and for that reason, we have to be very careful."

How a challenge would work

The volunteers would have to be people who are unlikely to need rescuing if the vaccine didn't work and they got sick, or if the vaccine caused an adverse reaction, Caplan said. That means the challenge would likely be conducted in younger people, those aged 18 to 29, a group with a death rate that hovers around 0.03% based on data from China.

This makes sense, but "at the same time, they're not going to be reflecting what happens immune-system wise to the most at-risk patients, which are the elderly," Kinch said. The immune systems of young people are very different compared with those of older people, he said. "Hopefully, you learn something from the healthiest and the least susceptible that can be applied to other groups," he added.

The challenge study would also need control groups who don't receive a vaccine and might become ill from the virus, the authors wrote in the study. Participants would need to be housed near a hospital and observed for a couple months pretty closely, Caplan said. One of the key requirements of such a study would be to pick people who are able to consent and who understand the risks of such an experiment. 

Related: 20 of the worst epidemics and pandemics in history

Researchers would need to get "very good consent" from these participants, quiz them to make sure they understand the dangers, make them sign a form, videotape them giving consent, and they should probably steer clear of paying them, Caplan said.  

"They have to be true volunteers with no ulterior motives or pressure to do this," Kinch said.

The first group of volunteers would likely be those who were previously exposed to the coronavirus and have antibodies to it, to determine whether or not those antibodies gave them full or partial immunity to a second exposure. Further studies would include people who haven't previously been exposed to the virus who would be given small doses first.

"That's hugely risky," Kinch said. If participants did become severely sick, they could be administered experimental drugs such as remdesivir or convalescent serum (blood from recovered patients that contains antibodies to fight the coronavirus), the authors wrote. "I'm optimistic about the early, early work that we're doing in convalescent serum," and you'd want those in hand, Kinch said. But there isn't a "cure" for the coronavirus and no treatment is completely effective.

Practically speaking, such a trial is probably not feasible. "Imagine who was going to sponsor that trial… they're going to be sued, guaranteed," he said. "Even if they're exempted from being sued, they're going to run the question of reputational risk."

A long-term side effect of such trials could be the anti-vaccination epidemic. "Vaccine skepticism is on the rise, we don't want to fuel that fringe conspiracy theory that they have," Kinch said. There's always a possibility that the vaccine won't work — or even worse, will enhance the adverse effects of the virus — which could fuel anti-vaccine sentiment, Kinch said. 

"If people start rejecting vaccines or seeing them as actively negative, many people could be harmed and killed for refusing to take vaccines," Kinch said. "There is a finite amount of credibility that the scientific and the medical establishment have with the general public, and we want to be very concerned about not wasting that credibility."

Originally published on Live Science.

OFFER: Save 45% on 'How It Works' 'All About Space' and 'All About History'!

For a limited time, you can take out a digital subscription to any of our best-selling science magazines for just $2.38 per month, or 45% off the standard price for the first three months.View Deal

  • Sopaconondas
    No!, no one should be injected or have the Coronavirus contagion deliberately to test a vaccine.
    This is what Albert Neisser did in 19th century Prussia with his syphilis vaccine, no syphilis vaccine ever worked; when some victims of experiment actually had syphilis, Neisser said it was because of their high risk behavior. This prompted the Prussian kingdom to issue the first rules ever about experiments in humans. The infamous Tuskegee and Central America experiments were a worse remake of Neisser crimes.
    The V-19 spreads fast, is an easy contagion, thus a cohort, observational study may perhaps go, HRA will say if a RND, placebo controlled trial is needed. This morality doubt arouse long time after Zidovudine was tested in Africa to block vertical transmission of HIV, newborn get it when going through delivery channel, this is the same rationale as in PrEP (Why the decades gap between Zidovudine for women about to delivery, and PrEP?), some claim about dubious morality of a RND, Placebo controlled trial, when an observational study may have been enough.
    For sure, double blind, placebo controlled studies provide the best evidence of activity for a registration, no way to accept a deliberate contagion of a potentially deadly virus to test efficacy of a vaccine, chances of contagion in an usual way of living can be assessed, and from this figures, the size of sample to be followed defined, the recent case of Dengue vaccine problems can be considered, but this differs in that is the second Dengue infection, or a first wild virus infection in a vaccinated subject what is more harmful, also the strains that produce the worse, more deadly second Dengue infection are those circulating in Asia, American Dengue strains are milder. Blessings +
    Reply
  • Joe Blaze
    first, do no harm? maybe i just imagined reading that at least a few times in the past,
    Reply
  • freddy
    Yes. First all the people that run Big Pharma and their families. Then then the politicians and their families. If they survive maybe on the general population. They are our leaders so they should go first. In the meantine I will keep my Vitamin D level at 50-70 take magnesium and zinc- B vitamins. I have not had the flu or cold for over 14 years now without the flu shot and at 68 never felt better.
    Reply
  • Joe Blaze
    i have the opposite to that freddy but over a much shorter time period. i havent been unwell in the 5 years since i had to start getting the flu shot.
    Reply
  • Urquiola
    About Flu shot, the later in season you get the shot, the higher your chances of minor symptoms, it may increase number of people with symptoms, but reduces flu mortality, coming mainly from bacterian pneumonia.
    I know no valid reason for those over 65 or with chronic diseases not having flu vaccine, but it is not mandatory; small pox vaccine was mandatory, disease was eradicated, same nearly happened with polio. Blessings +
    Reply
  • Joe Blaze
    Urquiola said:
    About Flu shot, the later in season you get the shot, the higher your chances of minor symptoms, it may increase number of people with symptoms, but reduces flu mortality, coming mainly from bacterian pneumonia.
    I know no valid reason for those over 65 or with chronic diseases not having flu vaccine, but it is not mandatory; small pox vaccine was mandatory, disease was eradicated, same nearly happened with polio. Blessings +

    i love the flu shot, i wasnt well for long periods over a few years and had to take too much time from work until they found out i had bad lungs. they reckon my teenage years of sniffing glue and smoking a lot of hash in the past done the damage but i havent been ill since.
    could you settle a bit of a bet? am sure 2 or 3 years ago when i was getting my flu shot that the nurse mentioned to me about it was impossible to have negative effects because the virus wasnt live but my brother got it last year and insists he was told the opposite. do you know the truth of that either way? cheers

    ok i read the answer again, should have done that before i asked lol. because you mention the syptoms am guessing i am mistaken about remembering the nurse tellng me that. am saying nothing to him though he can find out on his own now if he wants lol. i was just curious about that and was sure she told me.
    Reply
  • LindaG
    What is most scary about Human Challenge Testing is that the vaccine used will fail. There is no way to know in advance whether or not this will be the outcome. That will cause increased fear of vaccines and, at a minimum, reduce faith in finding a vaccine solution. It is a real conundrum for anyone involved with this decision, and in either case requires experience, in-depth knowledge, expertise, resolve, and bravado.
    Reply